2026 NPPES data Podiatrist NPI 1336136829 DPM
Verify on CMS →

MARK RAY, DPM

Podiatrist in LATROBE, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
522
Medicare Part D claims · 203 beneficiaries · Podiatrist avg: 304
Generic prescribing
94%
generic claims · 6% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$49.96
3 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARK RAY, DPM filed 522 Medicare Part D claims in 2023 as a Podiatrist in LATROBE, Pennsylvania, prescribing 94% generic.

522
Part D claims, 2023
94%
generic prescribing
$49.96
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK RAY, DPM's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

522 Top 34% higher than 66% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about MARK RAY, DPM?

Quality data not reported

NPI registry status

Active

Issued 09/30/2005

NPI 1336136829

Primary specialty

Podiatrist

Mid-sized

10,498 US NPIs in this specialty

Medicare Part D claims

522 72% vs specialty avg

2023 prescription claims

Specialty avg: 304

Specialty distribution in Pennsylvania

How Podiatrist compares to other specialties among Pennsylvania providers

Pennsylvania providers

Podiatrist share within Pennsylvania

1. Podiatrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Podiatrist share within Pennsylvania

Specialty board-certification context

Estimated specialty board-certified rate — Podiatrist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Podiatrist ABMS/AOA estimate

Est. board-certified rate (Podiatrist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Podiatrist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK RAY, DPM appears in the CMS NPPES registry as a Podiatrist provider holding DPM credentials at 5944 ROUTE 981, LATROBE, PA, 15650, with a listed phone of (724) 537-9008. NPI 1336136829 was issued on 09/30/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RAY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 522 prescription claims written by this provider, covering 203 Medicare beneficiaries and totaling roughly $21K in drug spend, split 6% brand-name and 94% generic by claim count, with an opioid prescribing rate of 7.9%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Podiatrist is a mid-sized specialty nationwide, with 10,498 enrolled providers across 54 states and an average of 304 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5944 ROUTE 981
LATROBE, PA 15650

Provider Details

NPI 1336136829
Specialty Podiatrist
Credentials DPM
Gender Male
NPI Issued 09/30/2005

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK RAY, DPM. Source: openpaymentsdata.cms.gov.

Total received

$50

Largest payer

Averitas Pharma Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to MARK RAY, DPM. To verify MARK RAY, DPM's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

MARK RAY, DPM — brand share 6.0%
Specialty average (est.)

6% brand-name claims vs 94% generic, on 522 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

522
Total Claims
$21K
Total Drug Cost
203
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
537
Total Day Supply
8,652
Brand vs Generic
6% brand / 94% generic
Brand Drug Cost
$14K
Generic Drug Cost
$6K
Opioid Claims
41 (7.9% rate)
Antibiotic Claims
175

Patient Demographics

Average Patient Age
73.9 years
Avg HCC Risk Score
1.58
Gender Split
50% female / 50% male
Age Distribution
<65: 23, 65-74: 81, 75-84: 79, 85+: 20

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARK RAY, DPM prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Cephalexin
91
Mupirocin
91
Terbinafine Hcl
55
Ketoconazole
33
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
32
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
27
Meloxicam
22
Amoxicillin
18
Gabapentin
17
Santyl
Collagenase Clostridium Hist.
17

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Podiatrist Overview

How MARK RAY, DPM fits within the Podiatrist landscape nationally.

10,498
Podiatrist Providers in US
54
States with Podiatrist
304
Avg Claims per Provider

MARK RAY, DPM's 522 claims are above the specialty average of 304.

Nearby Podiatrist Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as RAY.

Compare Podiatrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK RAY, DPM's specialty?
MARK RAY, DPM specializes in Podiatrist and practices in LATROBE, Pennsylvania. Credentials: DPM.
How much does MARK RAY, DPM prescribe under Medicare Part D?
In 2023, MARK RAY, DPM wrote 522 Medicare Part D claims totaling $21K in drug costs for 203 beneficiaries.
Where is MARK RAY, DPM located?
MARK RAY, DPM is located at 5944 ROUTE 981, LATROBE, PA, 15650. Phone: (724) 537-9008.
What is MARK RAY, DPM's NPI number?
MARK RAY, DPM's National Provider Identifier (NPI) is 1336136829, issued on 09/30/2005.
Does MARK RAY, DPM prescribe more brand-name or generic drugs?
MARK RAY, DPM's prescribing is 6% brand-name and 94% generic drugs by claim count, with $14K in brand drug costs.
Does MARK RAY, DPM prescribe opioids?
Yes, MARK RAY, DPM had 41 opioid claims in 2023 with an opioid prescribing rate of 7.9%.
How many Podiatrist providers are there in the US?
There are 10,498 Podiatrist providers across 54 states in the US. The average Podiatrist provider writes 304 Medicare Part D claims per year.
What drugs does MARK RAY, DPM prescribe most often?
Based on 2023 Medicare Part D data, MARK RAY, DPM's most frequently prescribed drugs include Cephalexin, Mupirocin, Terbinafine Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK RAY, DPM accept Medicare?
MARK RAY, DPM appears in CMS Medicare data with 522 Part D claims and 203 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK RAY, DPM's credentials?
MARK RAY, DPM's NPI is 1336136829 with credentials DPM. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology